Cargando…
Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway
Interleukin (IL)‐1β plays an important role in the pathogenesis of idiopathic pulmonary fibrosis. The production of IL‐1β is dependent upon caspase‐1‐containing multiprotein complexes called inflammasomes and IL‐1R1/MyD88/NF‐κB pathway. In this study, we explored whether a potential anti‐fibrotic ag...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082399/ https://www.ncbi.nlm.nih.gov/pubmed/27306439 http://dx.doi.org/10.1111/jcmm.12898 |
_version_ | 1782463050355310592 |
---|---|
author | Song, Cheng He, Lujuan Zhang, Jin Ma, Hong Yuan, Xiangning Hu, Gaoyun Tao, Lijian Zhang, Jian Meng, Jie |
author_facet | Song, Cheng He, Lujuan Zhang, Jin Ma, Hong Yuan, Xiangning Hu, Gaoyun Tao, Lijian Zhang, Jian Meng, Jie |
author_sort | Song, Cheng |
collection | PubMed |
description | Interleukin (IL)‐1β plays an important role in the pathogenesis of idiopathic pulmonary fibrosis. The production of IL‐1β is dependent upon caspase‐1‐containing multiprotein complexes called inflammasomes and IL‐1R1/MyD88/NF‐κB pathway. In this study, we explored whether a potential anti‐fibrotic agent fluorofenidone (FD) exerts its anti‐inflammatory and anti‐fibrotic effects through suppressing activation of NACHT, LRR and PYD domains‐containing protein 3 (NALP3) inflammasome and the IL‐1β/IL‐1R1/MyD88/NF‐κB pathway in vivo and in vitro. Male C57BL/6J mice were intratracheally injected with Bleomycin (BLM) or saline. Fluorofenidone was administered throughout the course of the experiment. Lung tissue sections were stained with haemotoxylin and eosin and Masson's trichrome. Cytokines were measured by ELISA, and α‐smooth muscle actin (α‐SMA), fibronectin, collagen I, caspase‐1, IL‐1R1, MyD88 were measured by Western blot and/or RT‐PCR. The human actue monocytic leukaemia cell line (THP‐1) were incubated with monosodium urate (MSU), with or without FD pre‐treatment. The expression of caspase‐1, IL‐1β, NALP3, apoptosis‐associated speck‐like protein containing (ASC) and pro‐caspase‐1 were measured by Western blot, the reactive oxygen species (ROS) generation was detected using the Flow Cytometry, and the interaction of NALP3 inflammasome‐associated molecules were measured by Co‐immunoprecipitation. RLE‐6TN (rat lung epithelial‐T‐antigen negative) cells were incubated with IL‐1β, with or without FD pre‐treatment. The expression of nuclear protein p65 was measured by Western blot. Results showed that FD markedly reduced the expressions of IL‐1β, IL‐6, monocyte chemotactic protein‐1 (MCP‐1), myeloperoxidase (MPO), α‐SMA, fibronectin, collagen I, caspase‐1, IL‐1R1 and MyD88 in mice lung tissues. And FD inhibited MSU‐induced the accumulation of ROS, blocked the interaction of NALP3 inflammasome‐associated molecules, decreased the level of caspase‐1 and IL‐1β in THP‐1 cells. Besides, FD inhibited IL‐1β‐induced the expression of nuclear protein p65. This study demonstrated that FD, attenuates BLM‐induced pulmonary inflammation and fibrosis in mice via inhibiting the activation of NALP3 inflammasome and the IL‐1β/IL‐1R1/MyD88/ NF‐κB pathway. |
format | Online Article Text |
id | pubmed-5082399 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50823992016-11-01 Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway Song, Cheng He, Lujuan Zhang, Jin Ma, Hong Yuan, Xiangning Hu, Gaoyun Tao, Lijian Zhang, Jian Meng, Jie J Cell Mol Med Original Articles Interleukin (IL)‐1β plays an important role in the pathogenesis of idiopathic pulmonary fibrosis. The production of IL‐1β is dependent upon caspase‐1‐containing multiprotein complexes called inflammasomes and IL‐1R1/MyD88/NF‐κB pathway. In this study, we explored whether a potential anti‐fibrotic agent fluorofenidone (FD) exerts its anti‐inflammatory and anti‐fibrotic effects through suppressing activation of NACHT, LRR and PYD domains‐containing protein 3 (NALP3) inflammasome and the IL‐1β/IL‐1R1/MyD88/NF‐κB pathway in vivo and in vitro. Male C57BL/6J mice were intratracheally injected with Bleomycin (BLM) or saline. Fluorofenidone was administered throughout the course of the experiment. Lung tissue sections were stained with haemotoxylin and eosin and Masson's trichrome. Cytokines were measured by ELISA, and α‐smooth muscle actin (α‐SMA), fibronectin, collagen I, caspase‐1, IL‐1R1, MyD88 were measured by Western blot and/or RT‐PCR. The human actue monocytic leukaemia cell line (THP‐1) were incubated with monosodium urate (MSU), with or without FD pre‐treatment. The expression of caspase‐1, IL‐1β, NALP3, apoptosis‐associated speck‐like protein containing (ASC) and pro‐caspase‐1 were measured by Western blot, the reactive oxygen species (ROS) generation was detected using the Flow Cytometry, and the interaction of NALP3 inflammasome‐associated molecules were measured by Co‐immunoprecipitation. RLE‐6TN (rat lung epithelial‐T‐antigen negative) cells were incubated with IL‐1β, with or without FD pre‐treatment. The expression of nuclear protein p65 was measured by Western blot. Results showed that FD markedly reduced the expressions of IL‐1β, IL‐6, monocyte chemotactic protein‐1 (MCP‐1), myeloperoxidase (MPO), α‐SMA, fibronectin, collagen I, caspase‐1, IL‐1R1 and MyD88 in mice lung tissues. And FD inhibited MSU‐induced the accumulation of ROS, blocked the interaction of NALP3 inflammasome‐associated molecules, decreased the level of caspase‐1 and IL‐1β in THP‐1 cells. Besides, FD inhibited IL‐1β‐induced the expression of nuclear protein p65. This study demonstrated that FD, attenuates BLM‐induced pulmonary inflammation and fibrosis in mice via inhibiting the activation of NALP3 inflammasome and the IL‐1β/IL‐1R1/MyD88/ NF‐κB pathway. John Wiley and Sons Inc. 2016-06-16 2016-11 /pmc/articles/PMC5082399/ /pubmed/27306439 http://dx.doi.org/10.1111/jcmm.12898 Text en © 2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Song, Cheng He, Lujuan Zhang, Jin Ma, Hong Yuan, Xiangning Hu, Gaoyun Tao, Lijian Zhang, Jian Meng, Jie Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway |
title | Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway |
title_full | Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway |
title_fullStr | Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway |
title_full_unstemmed | Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway |
title_short | Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL‐1β/IL‐1R1/MyD88/NF‐κB pathway |
title_sort | fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of nalp3 inflammasome and il‐1β/il‐1r1/myd88/nf‐κb pathway |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082399/ https://www.ncbi.nlm.nih.gov/pubmed/27306439 http://dx.doi.org/10.1111/jcmm.12898 |
work_keys_str_mv | AT songcheng fluorofenidoneattenuatespulmonaryinflammationandfibrosisviainhibitingtheactivationofnalp3inflammasomeandil1bil1r1myd88nfkbpathway AT helujuan fluorofenidoneattenuatespulmonaryinflammationandfibrosisviainhibitingtheactivationofnalp3inflammasomeandil1bil1r1myd88nfkbpathway AT zhangjin fluorofenidoneattenuatespulmonaryinflammationandfibrosisviainhibitingtheactivationofnalp3inflammasomeandil1bil1r1myd88nfkbpathway AT mahong fluorofenidoneattenuatespulmonaryinflammationandfibrosisviainhibitingtheactivationofnalp3inflammasomeandil1bil1r1myd88nfkbpathway AT yuanxiangning fluorofenidoneattenuatespulmonaryinflammationandfibrosisviainhibitingtheactivationofnalp3inflammasomeandil1bil1r1myd88nfkbpathway AT hugaoyun fluorofenidoneattenuatespulmonaryinflammationandfibrosisviainhibitingtheactivationofnalp3inflammasomeandil1bil1r1myd88nfkbpathway AT taolijian fluorofenidoneattenuatespulmonaryinflammationandfibrosisviainhibitingtheactivationofnalp3inflammasomeandil1bil1r1myd88nfkbpathway AT zhangjian fluorofenidoneattenuatespulmonaryinflammationandfibrosisviainhibitingtheactivationofnalp3inflammasomeandil1bil1r1myd88nfkbpathway AT mengjie fluorofenidoneattenuatespulmonaryinflammationandfibrosisviainhibitingtheactivationofnalp3inflammasomeandil1bil1r1myd88nfkbpathway |